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Selecting a single cell from a heterogeneous transfection pool that will scale-up appropriately from a micro-scale 
system to a commercial facility is a challenging and hugely important task. This clonal cell line needs to 
demonstrate the desired product quality attributes and ensure manufacturability throughout the entire drug 
manufacturing lifecycle. This process typically requires 6 to 12 months and is a time, capital and labour intensive 
process. High throughput (HT) methodologies are increasingly being adopted to speed up this cell line selection 
protocol. However, often the large quantities of data generated in combination with the increase in availability of 
analytics results in a daunting multivariate data analysis problem. Typically, the cell line selection strategy 
focuses on quality attributes recorded at point of harvest such as final concentrations of process parameters 
including titre and viable cell density, level of aggregates or addition product quality attributes. Time-series data 
such as dissolved oxygen, pH or gas flow rates are often overlooked due to challenges with visualization and 
interpretation of the large number of process variables recorded. This work describes a novel method that 
implements advanced multivariate tools including principal component analysis (PCA) to better leverage the 
available data to help guide this challenging decision making process. The inclusion of additional process 
variables was demonstrated to enhance the selection of a high-yielding mammalian cell line through inclusion of 
scale-up dependent process parameters related to high oxygen demands and varying nutrient uptake rates. 
Furthermore, this technique was demonstrated to highlight problematic product heterogeneities of parent clones 
that were not identified through univariate analysis of the multiple cell lines. The inclusion of this MVDA 
methodology demonstrated a more efficient and better decision-making protocol compared to conventional cell 
line selection processes. 
 
 
 
 
 
